Scholarly Index
Paolo Tarantino
Dana-Farber Cancer Institute; 5,364 total citations; 208 total publications; best world rank #15
Dana-Farber Cancer Institute
5,364Total citations
208Total publications
34H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Medical and Health Sciences | 2021-2025 | 529 | US 183 | 99.89 |
| Oncology | 2021-2025 | 61 | US 22 | 99.68 |
| Cancer Research | 2021-2025 | 42 | US 13 | 98.31 |
| Radiology, Nuclear Medicine and Imaging | 2021-2025 | 105 | US 31 | 98.23 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 268 | US 83 | 97.69 |
| HER2/EGFR in Cancer Research | Lifetime | 889 | US 403 | 96.50 |
| Advanced Breast Cancer Therapies | Lifetime | 484 | US 223 | 96.19 |
| Monoclonal and Polyclonal Antibodies Research | 2021-2025 | 15 | US 7 | 99.55 |
| Breast Cancer Treatment Studies | 2021-2025 | 30 | US 14 | 99.59 |
| HER2/EGFR in Cancer Research | 2021-2025 | 23 | US 10 | 99.50 |
| Cancer Treatment and Pharmacology | 2021-2025 | 54 | US 20 | 98.84 |
| CAR-T cell therapy research | 2021-2025 | 220 | US 122 | 98.44 |
| Advanced Breast Cancer Therapies | 2021-2025 | 63 | US 27 | 98.91 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 543 | US 204 | 97.88 |
| Cancer Genomics and Diagnostics | 2021-2025 | 923 | US 393 | 94.71 |
| Cancer Cells and Metastasis | 2021-2025 | 748 | US 185 | 86.09 |
| Breast Lesions and Carcinomas | 2021-2025 | 493 | US 156 | 82.31 |
| Multiple and Secondary Primary Cancers | 2021-2025 | 601 | US 211 | 74.10 |